Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dysregulation of mTOR Signaling in Neuropsychiatric Disorders: Therapeutic Implications

13 Dec 2011

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autism Spectrum Disorder Research
Share to Genetics and Neurodevelopmental Disorders
Share to Polyomavirus and related diseases

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 22157871
DOI: 10.1038/npp.2011.210

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dysregulation of mTOR Signaling in Neuropsychiatric Disorders: Therapeutic ImplicationsPMID 22157871Read ↗

The mTOR signalling cascade: paving new roads to cure neurological diseaseSemantic proximity Read ↗

PI3K-AKT/mTOR Signaling in Psychiatric Disorders: A Valuable Target to Stimulate or Suppress?Semantic proximity Read ↗

Dysregulation of the TSC-mTOR pathway in human diseaseSemantic proximity Read ↗

mTOR signaling as a molecular target for the alleviation of Alzheimer's disease pathogenesisSemantic proximity Read ↗

Oncogenes on my mind: ERK and MTOR signaling in cognitive diseasesSemantic proximity Read ↗

mTOR-Related Brain Dysfunctions in Neuropsychiatric DisordersSemantic proximity Read ↗

Molecular neurobiology of mTORSemantic proximity Read ↗

mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex ModelSemantic proximity Read ↗

From genes to cognition in tuberous sclerosis: implications for mTOR inhibitor-based treatment approaches.Semantic proximity Read ↗

Crosstalk between epigenetics and mTOR as a gateway to new insights in pathophysiology and treatment of Alzheimer's diseaseSemantic proximity Read ↗

mTOR signalling: jack-of-all-tradesSemantic proximity Read ↗

mTOR inhibitors in the pharmacologic management of tuberous sclerosis complex and their potential role in other rare neurodevelopmental disordersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.